CAH
Price
$161.41
Change
+$0.89 (+0.55%)
Updated
Jun 13 closing price
Capitalization
27.26B
52 days until earnings call
EDAP
Price
$1.71
Change
-$0.06 (-3.39%)
Updated
Jun 13 closing price
Capitalization
281.62M
65 days until earnings call
Interact to see
Advertisement

CAH vs EDAP

Header iconCAH vs EDAP Comparison
Open Charts CAH vs EDAPBanner chart's image
Cardinal Health
Price$161.41
Change+$0.89 (+0.55%)
Volume$2.72M
Capitalization27.26B
EDAP TMS SA
Price$1.71
Change-$0.06 (-3.39%)
Volume$32.41K
Capitalization281.62M
CAH vs EDAP Comparison Chart
Loading...
CAH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CAH vs. EDAP commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAH is a StrongBuy and EDAP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 16, 2025
Stock price -- (CAH: $161.41 vs. EDAP: $1.71)
Brand notoriety: CAH and EDAP are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: CAH: 117% vs. EDAP: 52%
Market capitalization -- CAH: $27.26B vs. EDAP: $281.62M
CAH [@Medical Distributors] is valued at $27.26B. EDAP’s [@Medical Distributors] market capitalization is $281.62M. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAH’s FA Score shows that 2 FA rating(s) are green whileEDAP’s FA Score has 0 green FA rating(s).

  • CAH’s FA Score: 2 green, 3 red.
  • EDAP’s FA Score: 0 green, 5 red.
According to our system of comparison, CAH is a better buy in the long-term than EDAP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAH’s TA Score shows that 4 TA indicator(s) are bullish while EDAP’s TA Score has 4 bullish TA indicator(s).

  • CAH’s TA Score: 4 bullish, 4 bearish.
  • EDAP’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CAH is a better buy in the short-term than EDAP.

Price Growth

CAH (@Medical Distributors) experienced а +4.33% price change this week, while EDAP (@Medical Distributors) price change was -3.93% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was -0.24%. For the same industry, the average monthly price growth was -0.06%, and the average quarterly price growth was -4.49%.

Reported Earning Dates

CAH is expected to report earnings on Aug 07, 2025.

EDAP is expected to report earnings on Aug 20, 2025.

Industries' Descriptions

@Medical Distributors (-0.24% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CAH($27.3B) has a higher market cap than EDAP($282M). EDAP has higher P/E ratio than CAH: EDAP (100.00) vs CAH (44.47). CAH YTD gains are higher at: 37.567 vs. EDAP (-22.624). CAH has higher annual earnings (EBITDA): 1.89B vs. EDAP (-18.39M). CAH has more cash in the bank: 4.59B vs. EDAP (43.5M). EDAP has less debt than CAH: EDAP (8.42M) vs CAH (4.72B). CAH has higher revenues than EDAP: CAH (216B) vs EDAP (60.4M).
CAHEDAPCAH / EDAP
Capitalization27.3B282M9,681%
EBITDA1.89B-18.39M-10,289%
Gain YTD37.567-22.624-166%
P/E Ratio44.47100.0044%
Revenue216B60.4M357,616%
Total Cash4.59B43.5M10,554%
Total Debt4.72B8.42M56,066%
FUNDAMENTALS RATINGS
CAH vs EDAP: Fundamental Ratings
CAH
EDAP
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
2100
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
391
P/E GROWTH RATING
1..100
92100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CAH's Valuation (72) in the Medical Distributors industry is in the same range as EDAP (99) in the Biotechnology industry. This means that CAH’s stock grew similarly to EDAP’s over the last 12 months.

CAH's Profit vs Risk Rating (2) in the Medical Distributors industry is significantly better than the same rating for EDAP (100) in the Biotechnology industry. This means that CAH’s stock grew significantly faster than EDAP’s over the last 12 months.

EDAP's SMR Rating (97) in the Biotechnology industry is in the same range as CAH (99) in the Medical Distributors industry. This means that EDAP’s stock grew similarly to CAH’s over the last 12 months.

CAH's Price Growth Rating (3) in the Medical Distributors industry is significantly better than the same rating for EDAP (91) in the Biotechnology industry. This means that CAH’s stock grew significantly faster than EDAP’s over the last 12 months.

CAH's P/E Growth Rating (92) in the Medical Distributors industry is in the same range as EDAP (100) in the Biotechnology industry. This means that CAH’s stock grew similarly to EDAP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAHEDAP
RSI
ODDS (%)
Bearish Trend 3 days ago
52%
Bearish Trend 6 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
58%
Bullish Trend 3 days ago
73%
Momentum
ODDS (%)
Bullish Trend 3 days ago
68%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
64%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
58%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 27 days ago
75%
Declines
ODDS (%)
Bearish Trend 6 days ago
46%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
53%
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
Bullish Trend 3 days ago
54%
Bullish Trend 3 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CAH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
E32.590.33
+1.02%
ENI SpA
LWAY24.92-0.22
-0.88%
Lifeway Foods
MOD93.72-3.35
-3.45%
Modine Manufacturing Co
ATUS2.05-0.10
-4.65%
Altice USA
MULN2.00-1.23
-38.08%
Mullen Automotive Inc

CAH and

Correlation & Price change

A.I.dvisor indicates that over the last year, CAH has been loosely correlated with COR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CAH jumps, then COR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAH
1D Price
Change %
CAH100%
+0.55%
COR - CAH
56%
Loosely correlated
+0.17%
MCK - CAH
52%
Loosely correlated
-0.36%
OMI - CAH
21%
Poorly correlated
-2.26%
HSIC - CAH
16%
Poorly correlated
-1.25%
COSM - CAH
14%
Poorly correlated
-5.57%
More

EDAP and

Correlation & Price change

A.I.dvisor tells us that EDAP and AHG have been poorly correlated (+18% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EDAP and AHG's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDAP
1D Price
Change %
EDAP100%
-3.39%
AHG - EDAP
18%
Poorly correlated
+2.33%
CAH - EDAP
15%
Poorly correlated
+0.55%
COR - EDAP
13%
Poorly correlated
+0.17%
ZYXI - EDAP
8%
Poorly correlated
+1.45%
YI - EDAP
8%
Poorly correlated
-1.24%
More